OCG Web Transition and Development

OCG Web 过渡和开发

• 批准号: 8654840
• 负责人: DAVID HEIMBROOK
• 金额: $ 15万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-09-26 至 2018-09-25
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8654840
• 关键词: Burkitt Lymphoma; Cancer Etiology; Clinical Data; Communities; Data Collection; Databases; Development; HIV; Internet; Malignant Neoplasms; Malignant neoplasm of anus; Malignant neoplasm of cervix uteri; Malignant neoplasm of lung; Office of Cancer Genomics; Patients; Technology; Tissues; large cell Diffuse non-Hodgkin' s lymphoma

Support to the NCI Office of Cancer Genomics (OCG) web development and transition for the HTCMP clinical data collection and database. The HTMCP project plans to study 100 cases each of three cancers: Diffuse Large B-cell lymphoma (DLBCL), lung cancer and cervical cancer from HIV+ patients. A small number of anal cancers may be added if tissues pass technical quality criteria as well as cases of HIV+ Burkitt Lymphoma. Additional support to develop projects that will examine how improvements in sequencing technologies can be efficiently and effectively applied to the understanding of cancer etiology. All results will be rapidly disseminated to the scientific community.

支持NCI癌症基因组学办公室（OCG）HTCMP临床数据收集和数据库的网络开发和过渡。HTMCP项目计划研究三种癌症中的每种100例：弥漫性大B细胞淋巴瘤（DLBCL），肺癌和宫颈癌。如果组织通过技术质量标准以及HIV+ Burkitt淋巴瘤的病例，则可能会增加少量肛门癌。额外的支持，以开发项目，将检查如何在测序技术的改进可以有效地应用于癌症病因的理解。所有结果将迅速传播给科学界。